Jung-Hyun Na

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Venues

Molecular pharmaceutics

Bioengineering (Basel, Switzerland)

Proteomics

Journal of agricultural and food chemistry

Sangji University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sangji University Mar 01 2020

South Korea

Assistant Professor :: Pharmaceutical Engineering

Osong Medical Innovation Foundation Jul 31 2018 - Feb 29 2020

South Korea

Researcher :: Antibody Drug Team

Kookmin University Sep 18 2017 - Jul 30 2018

South Korea

Research Professor :: Department of Applied Chemistry

Ewha Womans University May 01 2016 - Aug 31 2017

South Korea

Post Doctoral Scientist :: Department of Chemistry and Nanoscience

Korea Institute of Ocean Science and Technology Aug 04 2014 - Apr 30 2016

South Korea

Research Scientist :: Marine Biotechnology Research Center

Korea Institute of Science and Technology Aug 22 2012 - Aug 03 2014

South Korea

Student Scientist :: Center for Theragnosis

Publications

Woo Sung Kim, Ji Hyun Kim, Jisun Lee, Su Yeon Ka, Hee Do Chae, Inji Jung, Sang Taek Jung, Jung-Hyun Na
Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli . Bioengineering (Basel, Switzerland) 9 (11) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Amir Khan, Ji-Yon Shin, Min Kyung So, Jung-Hyun Na, Sune Justesen, Adnan Ahmad Ansari, Byoung Joon Ko, Sung-Min Ahn
Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics (2021)
Sanghwan Ko, Bora Hwang, Jung-Hyun Na, Jisun Lee, Sang Taek Jung
Engineered Arabidopsis Blue Light Receptor LOV Domain Variants with Improved Quantum Yield, Brightness, and Thermostability. Journal of agricultural and food chemistry 67 (43) (2019)
Jung-Hyun Na, Won Kyu Lee, Yeon Gyu Yu
How Do We Study the Dynamic Structure of Unstructured Proteins: A Case Study on Nopp140 as an Example of a Large, Intrinsically Disordered Protein. International journal of molecular sciences 19 (2) (2018)
Young Jun An, Sara E Rowland, Jung-Hyun Na, Dario Spigolon, Seung Kon Hong, Yeo Joon Yoon, Jung-Hyun Lee, Frank T Robb, Sun-Shin Cha
Structural and mechanistic characterization of an archaeal-like chaperonin from a thermophilic bacterium. Nature communications 8 (1) (2017)

Jung-Hyun Na.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jung-Hyun Na